Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells $16,295.92 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 604 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total value of $16,295.92. Following the completion of the sale, the senior vice president now directly owns 115,029 shares in the company, valued at $3,103,482.42. This trade represents a 0.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Price Performance

Phreesia stock opened at $27.24 on Monday. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The company’s 50 day moving average price is $23.54 and its two-hundred day moving average price is $22.83. The stock has a market cap of $1.58 billion, a P/E ratio of -18.53 and a beta of 0.94. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.58) earnings per share. On average, equities analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Trading of Phreesia

A number of large investors have recently added to or reduced their stakes in the stock. Wesbanco Bank Inc. boosted its stake in Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after acquiring an additional 20,000 shares during the last quarter. Franklin Resources Inc. grew its holdings in Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the period. Geode Capital Management LLC increased its position in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. M&T Bank Corp raised its stake in shares of Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after buying an additional 1,535 shares during the period. Finally, Barclays PLC grew its stake in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after acquiring an additional 43,225 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analyst Ratings Changes

PHR has been the subject of several research reports. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Robert W. Baird cut their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Truist Financial lifted their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. KeyCorp increased their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Finally, Citigroup lifted their target price on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.